Navigation Links
Personalized Stem Cells, Inc. Sponsors Arthritis Foundation Event in Los Angeles
Date:11/27/2019

Personalized Stem Cells, Inc (“PSC”), a human adipose-derived stem cell company, recently sponsored an event put on by the Arthritis Foundation and hosted by Dr. Steven Sampson and Dr. Danielle Aufiero of the Orthohealing Center in Los Angeles, California. The event, which took place on October 23, 2019, highlighted the ongoing efforts to promote research, educate the public, and provide support to people with arthritis.

Event attendees included medical doctors, physical therapists, chiropractors, and other medical professionals. Dr. Sampson presented current and evolving regenerative and stem cell therapies, including PSC’s FDA approved clinical trial to treat osteoarthritis in the knee with a person’s own stem cells. The Orthohealing Center is one of several approved clinical trial sites and is currently screening and enrolling patients in the clinical trial.

PSC CEO, Michael Dale, stated, “It is an honor to help support the Arthritis Foundation and to work closely with the Orthohealing Center. The Foundation and the Orthohealing Center have worked together for many years advocating and spreading awareness for arthritis patients.”

PSC provides stem cell therapy for clinical trial investigators and their patients, working within the FDA cell therapy regulations in order to assure consistent manufacturing, quality tested cells, as well as clinical trial and manufacturing oversite for safety and efficacy. PSC was founded by Robert Harman, DVM, MPVM and Michael Dale, both of whom also co-founded VetStem Biopharma and are both experienced serial entrepreneurs.

About Personalized Stem Cells, Inc.
Personalized Stem Cells was formed in 2018 to advance and legitimize human regenerative medicine. This privately held biopharmaceutical enterprise, based near San Diego (California), offers qualified physicians who enroll, an FDA compliant autologous stem cell product (from patient’s own fat tissue) for use in FDA approved clinical trials. PSC is driving development and adoption of stem cell and regenerative medicine within the FDA-IND process by providing cGMP manufactured, quality tested cells, and well-defined clinical trials. PSC has licensed a portfolio of over 70 issued patents in the field of regenerative medicine.

Read the full story at https://www.prweb.com/releases/personalized_stem_cells_inc_sponsors_arthritis_foundation_event_in_los_angeles/prweb16748973.htm.


'/>"/>
Source: PRWeb
Copyright©2019 Vocus, Inc.
All rights reserved


Related biology news :

1. Personalized Stem Cells, Inc. Announces First Patients Treated in FDA Approved Clinical Trial for Treatment of Osteoarthritis with Stem Cells
2. Personalized Stem Cells, Inc. Announces First Patients Enrolled in FDA Approved Clinical Trial for Treatment of Osteoarthritis with Stem Cells
3. VetStem Biopharma Secures FDA Approval of First Human IND for its Subsidiary, Personalized Stem Cells, Inc.
4. Personalized Stem Cells, Inc. Announces FDA Approval of IND Application for Treatment of Osteoarthritis with Stem Cells
5. Personalized Medicine: A New Approach to Treat Periodontal Diseases
6. Zipongo Incorporates 23andMe Reports Into Personalized Nutrition Plans
7. Personalized Medicine - Scientific and Commercial Aspects - 318 Companies Profiled with 575 Collaborations - Research and Markets
8. NXT-ID Patents Personalized Tokenized Payments for Next Generation Secure Payment Technology
9. @USANAincs Personalized Nutrition Program Wins Industry Innovation Award
10. "Personalized Medicine in Human Space Flight" Listed Among Most Influential Papers of 2013 and 2014
11. Epic Sciences to Present at Personalized Medicine World Conference 2015 on the Use of Circulating Tumor Cells as Cancer Biomarkers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/6/2020)... ... February 06, 2020 , ... Kerafast Inc. , ... materials, today announced an agreement with The Good Food Institute , a ... Under the partnership, terrestrial meat and aquatic cell lines will be made available ...
(Date:1/29/2020)... PARK, N.C. (PRWEB) , ... January 29, 2020 ... ... partner to lead the new Analytics and Data Sciences practice, providing consulting services ... clients. Burke’s appointment was announced by Mike Townley, co-founder and Managing Partner of ...
(Date:1/27/2020)... ... 2020 , ... On Thursday, February 20, 2020 at 10am EST (3pm GMT/UK), ... and Richard Castle, Global Account Manager Medical Device at PRISYM ID for ... MDR timing deadlines, best practices in creating and submitting product data and best practices ...
Breaking Biology News(10 mins):
(Date:1/27/2020)... , ... January 27, 2020 , ... ... it has secured financing from strategic investors led by Halma plc , ... existing investors Sonion, TDF Ventures, GII LLC, and WSJ Joshua Fund. A representative ...
(Date:1/24/2020)... ... January 24, 2020 , ... ... RedySmart™ mass flow meters and controllers ideal for BioPharm OEMS. Sierra ... to antiquated rotameters. These thermal instruments employ high-precision MEMS (Micro-Electro Mechanical Systems) technology ...
(Date:1/22/2020)... FRANKLIN, Wis. (PRWEB) , ... January 21, 2020 ... ... announce the hiring of Darrell Taylor as Southern Midwest Region Industrial and Institutional ... to the SporActiv™ product line. , Darrell brings over 30 years ...
(Date:1/10/2020)... , ... January 09, 2020 , ... ... Drug Development establishes benchmarks for the vendor qualification process, a critical element ... the process volume and complexity of the vendor qualification process creates delays in ...
Breaking Biology Technology: